BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 18647814)

  • 1. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.
    Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3995-8. PubMed ID: 18647814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility.
    MacIntosh CG; Andrews JM; Jones KL; Wishart JM; Morris HA; Jansen JB; Morley JE; Horowitz M; Chapman IM
    Am J Clin Nutr; 1999 May; 69(5):999-1006. PubMed ID: 10232642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal.
    Ellrichmann M; Ritter PR; Otte JM; Schrader H; Banasch M; Brunke G; Herzig KH; Seebeck J; Schmidt WE; Schmitz F
    Regul Pept; 2007 Mar; 139(1-3):136-40. PubMed ID: 17175037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial effects of polydextrose on satiety hormone responses and subjective feelings of appetite in obese participants.
    Olli K; Salli K; Alhoniemi E; Saarinen M; Ibarra A; Vasankari T; Rautonen N; Tiihonen K
    Nutr J; 2015 Jan; 14():2. PubMed ID: 25555562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons.
    Di Francesco V; Zamboni M; Dioli A; Zoico E; Mazzali G; Omizzolo F; Bissoli L; Solerte SB; Benini L; Bosello O
    J Gerontol A Biol Sci Med Sci; 2005 Dec; 60(12):1581-5. PubMed ID: 16424292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men.
    Degen L; Drewe J; Piccoli F; Gräni K; Oesch S; Bunea R; D'Amato M; Beglinger C
    Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1391-9. PubMed ID: 17138722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term inhibition of intestinal lipase by orlistat improves release of gut hormones increasing satiety in obese women.
    Olszanecka-Glinianowicz M; Dąbrowski P; Kocełak P; Janowska J; Smertka M; Jonderko K; Chudek J
    Pharmacol Rep; 2013; 65(3):666-71. PubMed ID: 23950589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of L-Phenylalanine on Energy Intake and Glycaemia-Impacts on Appetite Perceptions, Gastrointestinal Hormones and Gastric Emptying in Healthy Males.
    Fitzgerald PCE; Manoliu B; Herbillon B; Steinert RE; Horowitz M; Feinle-Bisset C
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32560181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
    Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M
    J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans.
    Feinle C; O'Donovan D; Doran S; Andrews JM; Wishart J; Chapman I; Horowitz M
    Am J Physiol Gastrointest Liver Physiol; 2003 May; 284(5):G798-807. PubMed ID: 12684211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).
    Blanco AM; Bertucci JI; Valenciano AI; Delgado MJ; Unniappan S
    Horm Behav; 2017 Jul; 93():62-71. PubMed ID: 28506816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.
    Morínigo R; Moizé V; Musri M; Lacy AM; Navarro S; Marín JL; Delgado S; Casamitjana R; Vidal J
    J Clin Endocrinol Metab; 2006 May; 91(5):1735-40. PubMed ID: 16478824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety.
    Gibbons C; Caudwell P; Finlayson G; Webb DL; Hellström PM; Näslund E; Blundell JE
    J Clin Endocrinol Metab; 2013 May; 98(5):E847-55. PubMed ID: 23509106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a lipase inhibitor (Orlistat) on cholecystokinin and appetite in response to a high-fat meal.
    Goedecke JH; Barsdorf M; Beglinger C; Levitt NS; Lambert EV
    Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1479-85. PubMed ID: 14634678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects.
    Enç FY; Ones T; Akin HL; Dede F; Turoğlu HT; Ulfer G; Bekiroğlu N; Haklar G; Rehfeld JF; Holst JJ; Ulusoy NB; Imeryüz N
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G482-9. PubMed ID: 19109408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
    Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.
    Flint A; Raben A; Ersbøll AK; Holst JJ; Astrup A
    Int J Obes Relat Metab Disord; 2001 Jun; 25(6):781-92. PubMed ID: 11439290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes.
    O'Donovan D; Horowitz M; Russo A; Feinle-Bisset C; Murolo N; Gentilcore D; Wishart JM; Morris HA; Jones KL
    Diabetologia; 2004 Dec; 47(12):2208-14. PubMed ID: 15662558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive.
    Arusoglu G; Koksal G; Cinar N; Tapan S; Aksoy DY; Yildiz BO
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4475-82. PubMed ID: 24001751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.